ClinicalTrials.gov
public full text
Public Domain
Quality of Life, Recombinant TSH (Thyrogen) and Thyroid Cancer
To evaluate quality of life in patients after 10 days pause of thyroid medication (Liothyronine) compared to treatment with recombinant TSH (Thyrogen) before radioiodine uptake and treatment in a double-blinded, randomised cross-over design.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- TSI and Its Relationship With Graves' Disease Relapse#813951
- Necessity of TSH Suppression Therapy in Active Surveillance for Thyroid Cancer Patients.#1057995
- Thyroid Cancer in Surgical Treated Multinodular Goiter#872841
- The burden of thyroid eye disease: Evaluating treatment outcomes on quality of life.#298695
- SMART TNT for the Conservative Management of Locally Advanced Rectal Cancer#863357
Record · ID 1162961
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive